-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Category Archives: Corporate
Latest From Corporate
Twenty Years & Counting: Welcome to Chicago!
Welcome to the 2013 BIO International Convention. It is hard to believe, but this year BIO reaches a significant milestone as we celebrate 20 years of bringing innovation, opportunity and growth to an industry that heals, fuels and feeds the world. From a small beginning – less than 1,500 people attended the first BIO meeting in 1993 – our Convention has grown into the most influential biotech gathering in the world, attracting thousands of industry Read More >
How Countries Can Boost Their Biotech Industry
How can countries and regions boost the biotech industry within their borders? Working with several member companies, BIO developed a Global Policy Platform to serve as a roadmap for policymakers seeking to create an environment for the biotech industry to grow and prosper. These policy principles include four components: (i) research collaboration; (ii) intellectual property rights; (iii) regulatory approval; and (iv) market access. In addition, the Global Policy Platform includes best practices from around the Read More >
Thoughts on the President’s State of the Union
I had several thoughts watching President Obama’s State of the Union Address tonight. First, we at BIO remain concerned about the possible impact that sequestration may have – specifically the potential impact it may have on human health. There are millions of patients – all hopeful that new treatments will become available soon. Our fear is that sequestration may impact the ability of those patients to access new treatments in a timely manner. That fear Read More >
Biotech Hall of Fame: Interview with Biotech’s First Investment Banker
Earlier this week, I had the opportunity to discuss biotech’s storied history with Fred Frank, one of the industry’s greatest luminaries, on what we can learn from the past to help shape the future. Fred Frank, formerly Vice Chairman of both Lehman Brothers Inc. and Peter J. Solomon Company, recently became Vice Chairman of Burrill & Company and Chairman of Burrill Securities, the broker dealer arm of Burrill & Company. He was the first life Read More >
A Call to Arms for Renewable Fuels
BIO President & CEO Jim Greenwood delivered remarks on the Renewable Fuel Standard and participated in a panel session on the Legacy of Bipartisan Support for Renewable Energy at ACORE’s National Renewable Energy Policy Forum, held on Capitol Hill: Good afternoon. It is good to be with ACORE again and to be part of your 10th annual policy forum. I had the pleasure of speaking at the RETECH 2012 conference in October. I said then Read More >
